Market Closed -
Other stock markets
|
After market 12:38:32 pm | |||
68 EUR | +1.64% | 67.9 | -0.15% |
12:00am | MorphoSys AG(XTRA:MOR) dropped from S&P Global BMI Index | CI |
Jun. 06 | MorphoSys AG Announces Board Changes | CI |
Business Summary
Number of employees: 464
Sales per Business
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Innovative Cancer Medicines
100.0
%
| 278 | 100.0 % | 238 | 100.0 % | -14.37% |
Sales per region
EUR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
88.8
%
| 0 | 0.0 % | 211 | 88.8 % | - |
Europe (excluding Germany)
11.2
%
| - | - | 27 | 11.2 % | - |
Asia
0.0
%
| - | - | 0 | 0.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Luisa Ciccarelli
CTO | Chief Tech/Sci/R&D Officer | - | 21-07-31 |
Tim Demuth
CTO | Chief Tech/Sci/R&D Officer | 50 | 22-09-30 |
Julia Neugebauer
IRC | Investor Relations Contact | - | 06-08-31 |
Daniel Palmacci
PRN | Corporate Officer/Principal | - | 20-06-30 |
Ann Merchant
PRN | Corporate Officer/Principal | 59 | 17-12-31 |
Ralf Ostendorp
PRN | Corporate Officer/Principal | - | 98-12-31 |
Corporate Officer/Principal | - | 94-04-30 | |
Klaus de Wall
AUD | Comptroller/Controller/Auditor | - | 05-05-31 |
Corporate Officer/Principal | - | 97-12-31 | |
Human Resources Officer | 54 | 12-05-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Sharon Curran
BRD | Director/Board Member | 56 | 19-05-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 37,716,423 | 6,497,716 ( 17.23 %) | 53,685 ( 0.1423 %) | 17.23 % |
Company contact information
Sector
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+100.00% | 2.72B | |
+48.15% | 57.87B | |
+41.65% | 40.25B | |
-7.20% | 39.94B | |
-5.96% | 28.54B | |
+12.17% | 26.4B | |
-20.09% | 19.33B | |
+30.11% | 12.4B | |
-0.72% | 12.23B | |
+24.48% | 12.2B |
- Stock Market
- Equities
- MOR Stock
- Company MorphoSys AG